Sorin Dojan, Investment Week, 19 March 2025: Internalising management for REITs removes the risk of further complicating cost reporting for investment trusts, but experts warn the advantages of an externally managed vehicle are also taken away. Their caution came after Supermarket Income REIT (SUPR) put forward proposals to internalise its management function, subject to shareholder […]
by Val Cipriani, Investors Chronicle, March 18, 2025: Shares in capital preservation investment trusts have stayed broadly flat during the latest market sell-off, providing better shelter than during the 2022 bear market. The three defensive wealth preservation trusts, Capital Gearing (CGT), Personal Assets (PNL) and Ruffer Investment Company (RICA), had around 30 per cent of […]
By ROSIE MURRAY-WEST and SIMON LAMBERT, This is Money, 18 March 2025: An income you don’t have to work for is often seen as the preserve of fortunate ‘trustafarians’, whose families use trusts to pass wealth down through the generations. But you can use your Isa to provide your family with a source of tax-free […]
Investment trust insider on Fidelity China Special Situations – James Carthew: My China fund is up 60% in six months and has further to go As US markets finally come off the boil, our columnist explains why he is sticking with Fidelity China Special Situations and how the £1.4bn trust makes good use of the […]
Investment trust insider on Achilles and North Atlantic Smaller – James Carthew: Activist Achilles and the wide discounts on Chris Mills’ other trusts Our columnist responds to questions about how recently-launched Achilles can attack other trusts for being on discounts when North Atlantic Smaller Companies, run by one of the same managers, trades one-third below […]
Investment trust insider compares Biotech Growth and International Biotechnology – James Carthew: Am I too late to switch biotech trust? Our columnist is disappointed by Biotech Growth Trust’s returns over the past decade and wonders whether rival International Biotechnology is now more compelling. Biotech Growth Trust (BIOG) has been on a rollercoaster ride over the […]
By Matteo Anelli, Senior reporter, Trustnet, 03 March 2025: RIT Capital Partners has disclosed a new position in SpaceX, initiated in the second half of 2024, in its full-year results released this morning. The investment trust noted in the 12 months to the end of December, the net asset value (NAV) rose 7.7% (9.4% including […]
Linus Uhlig, Investment Week, 28 February 2025: Saba Capital, the US activist hedge fund causing waves through the investment trust sector, has been accused of “making it up as they go along” by industry commentators. Earlier in February, with six out of six vote losses under its belt and an admittance from the hedge fund’s […]
by Dave Baxter, Investors Chronicle, February 28, 2025: Equity income investors have many ways to skin a cat. One debate of recent years, for instance, has focused on whether to hold shares that already pay out cash, or to instead invest in something in the hope of making healthy gains, then take an income by […]
Questor on JPMorgan Japanese – How to buy local knowledge in Warren Buffett’s favourite foreign market With managers based in Tokyo, this Japanese trust continues to outperform Japan is back – just ask Warren Buffett. Much like the nation, many investment trusts focused on Japan have been through periods of difficulty, although few lasted as […]
